Cargando…
Sarcopenia and COVID-19 Outcomes
Coronavirus disease 2019 (COVID-19) spread rapidly and became a severe global public health threat. Older adults have a high risk of COVID-19 and its associated mortality. Sarcopenia has emerged as a predictor of poor outcomes in COVID-19 patients, including lengthy hospital stays, mortality, intens...
Autores principales: | Wang, Yuhan, Tan, Shuwen, Yan, Qihui, Gao, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010141/ https://www.ncbi.nlm.nih.gov/pubmed/36923269 http://dx.doi.org/10.2147/CIA.S398386 |
Ejemplares similares
-
Post-COVID-19 acute sarcopenia: physiopathology and management
por: Piotrowicz, Karolina, et al.
Publicado: (2021) -
Screening for Sarcopenia (Physical Frailty) in the COVID-19 Era
por: Ali, Amira Mohammed, et al.
Publicado: (2021) -
COVID-19 and Acute Sarcopenia
por: Welch, Carly, et al.
Publicado: (2020) -
Clinical Outcomes and Prevalence of Sarcopenia in Patients with Moderate to Severe COVID-19
por: Yamamoto, Shuhei, et al.
Publicado: (2022) -
Malnutrition and Sarcopenia in COVID-19 Survivors
por: Grund, Stefan, et al.
Publicado: (2022)